Group One Trading
CELU icon

Group One Trading’s Celularity CELU Stock Holding History

Group One Trading’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Buy
3,595
+3,500
+3,684% +$3.36K ﹤0.01% 7021
2026
Q1 		$126 Buy
+95
New +$120 ﹤0.01% 7419
2025
Q3 		– Sell
-25,173
Closed -$70.5K – 8469
2025
Q2 		$49.3K Sell
25,173
-1,070
-4% -$1.95K ﹤0.01% 5583
2025
Q1 		$45.4K Buy
26,243
+9,650
+58% +$18.3K ﹤0.01% 5245
2024
Q4 		$34.5K Buy
+16,593
New +$39.6K ﹤0.01% 5337
2024
Q1 		– Sell
-3,849
Closed -$9.52K – 7124
2023
Q4 		$9.52K Hold
3,849
– – ﹤0.01% 6237
2023
Q3 		$8.55K Hold
3,849
– – ﹤0.01% 6435
2023
Q2 		$20.5K Hold
3,849
– – ﹤0.01% 5978
2023
Q1 		$23.9K Sell
3,849
-1,152
-23% -$9.27K ﹤0.01% 5387
2022
Q4 		$64.5K Buy
5,001
+2,817
+129% +$51.9K ﹤0.01% 4805
2022
Q3 		$50K Buy
+2,184
New +$66.3K ﹤0.01% 5401
2021
Q4 		– Sell
-2,125
Closed -$136K – 8251
2021
Q3 		$150K Sell
2,125
-4,524
-68% -$365K ﹤0.01% 5476
2021
Q2 		$677K Sell
6,649
-3,140
-32% -$318K ﹤0.01% 3876
2021
Q1 		$987K Buy
+9,789
New +$1M ﹤0.01% 3246

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Group One Trading's CELU Position: Q2 2026 in Review

Group One Trading increased its Celularity (CELU) stake by 3,684% in Q2 2026, buying an estimated $3.36K and bringing the position to 3,595 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #7021.

Group One Trading first reported a position in CELU in Q1 2021 and has held it in 14 quarters since. The position peaked at $987K in Q1 2021. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Group One Trading held 3,595 shares of Celularity worth $2.15K as of Q2 2026.
  • Group One Trading bought 3,500 Celularity shares in Q2 2026, an estimated $3.36K.
  • Celularity made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7021 holding.
  • Group One Trading first reported a position in Celularity in Q1 2021 and has held it in 14 quarters since.
  • Group One Trading's Celularity position peaked at $987K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.